MapLight Therapeutics, Inc. (MPLT)
11.35
+0.14
(+1.25%)
USD |
NASDAQ |
Aug 24, 16:00
11.35
0.00 (0.00%)
After-Hours: 20:00
MapLight Therapeutics Enterprise Value : 206.61M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 206.61M |
| August 20, 2026 | 207.52M |
| August 19, 2026 | 249.32M |
| August 18, 2026 | 234.33M |
| August 17, 2026 | 208.20M |
| August 14, 2026 | 231.15M |
| August 13, 2026 | 223.42M |
| August 12, 2026 | 214.33M |
| August 11, 2026 | 241.60M |
| August 10, 2026 | 250.68M |
| August 07, 2026 | 250.23M |
| August 06, 2026 | 300.66M |
| August 05, 2026 | 284.31M |
| August 04, 2026 | 285.22M |
| August 03, 2026 | 267.50M |
| July 31, 2026 | 288.85M |
| July 30, 2026 | 334.74M |
| July 29, 2026 | 379.72M |
| July 28, 2026 | 256.59M |
| July 27, 2026 | 147.31M |
| July 24, 2026 | 1.358B |
| July 23, 2026 | 1.298B |
| July 22, 2026 | 1.302B |
| July 21, 2026 | 1.398B |
| July 20, 2026 | 1.333B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.418B |
| July 16, 2026 | 1.388B |
| July 15, 2026 | 1.393B |
| July 14, 2026 | 1.420B |
| July 13, 2026 | 1.359B |
| July 10, 2026 | 1.484B |
| July 09, 2026 | 1.506B |
| July 08, 2026 | 1.448B |
| July 07, 2026 | 1.381B |
| July 06, 2026 | 1.289B |
| July 02, 2026 | 1.383B |
| July 01, 2026 | 1.337B |
| June 30, 2026 | 1.326B |
| June 29, 2026 | 1.246B |
| June 26, 2026 | 1.200B |
| June 25, 2026 | 1.140B |
| June 24, 2026 | 1.081B |
| June 23, 2026 | 990.26M |
| June 22, 2026 | 1.042B |
| June 18, 2026 | 998.40M |
| June 17, 2026 | 1.016B |
| June 16, 2026 | 923.35M |
| June 15, 2026 | 959.52M |
| June 12, 2026 | 950.02M |
| June 11, 2026 | 1.068B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Evommune, Inc. | 316.51M |
| Sarepta Therapeutics, Inc. | 2.242B |
| Cullinan Therapeutics, Inc. | 1.067B |
| Mineralys Therapeutics, Inc. | 1.702B |
| Apogee Therapeutics, Inc. | 9.286B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.19M |
| Total Expenses (Quarterly) | 60.19M |
| EPS Diluted (Quarterly) | -1.325 |
| Earnings Yield | -45.13% |
| Normalized Earnings Yield | -45.13 |